Optimi Health Corp.

Optimi Health Corp. is a Canadian pharmaceutical company specializing in the research, development, manufacturing, and global supply of psychedelic substances. Licensed by Health Canada, Optimi Health is notable for holding both a Controlled Substances Dealer’s Licence and a Drug Establishment Licence, enabling it to produce and distribute regulated compounds such as botanical psilocybin and MDMA. The company operates out of purpose-built, GMP-compliant facilities in Princeton, British Columbia, which together span 20,000 square feet and ensure rigorous quality control throughout cultivation, formulation, and analytical processes. Optimi’s product offerings include proprietary drug formulations, active pharmaceutical ingredients, and finished drug products, serving researchers, drug developers, and authorized patients around the world. With a focus on strict compliance and quality, Optimi Health plays a significant role in advancing the accessibility and credibility of psychedelic therapies, particularly for conditions like PTSD and treatment-resistant depression. Additionally, Optimi Health contributes to the broader health and wellness sector through functional mushroom products and active engagement with international regulatory and patient advocacy initiatives.